Skip to main content

Spider web

Archived Page

This page has been archived and is provided for historical reference purposes only. The content and links are no longer maintained and may now be outdated.

NHGRI Webinar Series: All About the Genetic Information Non-Discrimination Act of 2008 (GINA)

People with double helix and the letters A T C G in the background

What is GINA? How will it affect me? How will I - and my family - be protected? NHGRI Acting Director Alan Guttmacher, NHGRI Senior Health Policy Analyst M.K. Holohan and President and CEO of the Genetic Alliance Sharon Terry discussed these GINA topics and more on July 17, 2008 at 1 p.m. Eastern.

YouTube video Watch the Webinar
Read the TranscriptPDF file

GINA: Related Resources

About the Speakers

Alan E. Guttmacher, M.D. Alan E. Guttmacher, M.D., Ph.D.
Acting Director
National Human Genome Research Institute
National Institutes of Health
Bethesda, MD

Alan Guttmacher, M.D., is the Deputy Director of the National Human Genome Research Institute (NHGRI), helping oversee the institute's efforts in advancing genome research, integrating the benefits of genome research into health care, and exploring the ethical, legal, and social implications of human genomics. Dr. Guttmacher also serves as the Director of the Office of Policy, Communications, and Education at the NHGRI. In that role, he directs the institute's health affairs, public policy, communications, community outreach and public education functions.

M. K. Holohan, J.D. M.K. Holohan Quattrocchi, J.D.
Health Policy Analyst
National Human Genome Research Institute
Bethesda, MD

M.K. Holohan is a Senior Health Policy Analyst at the National Human Genome Research Institute at the National Institutes of Health. Her primary focus is on legislation and government relations, and policy issues related to genetic information, including nondiscrimination issues, regulation and privacy considerations. Prior to joining the NIH, Ms. Holohan worked as an attorney in a litigation practice, and also has extensive experience in clinical research in oncology and HIV/AIDS.

Sharon Terry, M.A. Sharon Terry, M.A.
President and CEO
Genetic Alliance
Washington, D.C.

Sharon Terry is President and CEO of the Genetic Alliance, a network transforming health by promoting an environment of openness centered on the health of individuals, families and communities. She is the founding Executive Director of PXE International, a research advocacy organization for the genetic condition pseudoxanthoma elasticum (PXE).

For more information on the Genetic Alliance, please visit

Top of page

Last Reviewed: November 8, 2012